Table of Contents Author Guidelines Submit a Manuscript
Neuroscience Journal
Volume 2013 (2013), Article ID 870608, 7 pages
http://dx.doi.org/10.1155/2013/870608
Research Article

The Triglyceride Paradox in Stroke Survivors: A Prospective Study

1Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY 14627, USA
2Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
3Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
4Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY 14627, USA
5Departments of Emergency Medicine and Neurological Surgery, University of Florida College of Medicine, Gainesville, FL 32608, USA

Received 14 October 2012; Revised 22 January 2013; Accepted 22 January 2013

Academic Editor: Pasquale Striano

Copyright © 2013 Minal Jain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bogousslavsky, J. Aarli, and J. Kimura, “Stroke and neurology: a plea from the WFN,” Lancet Neurology, vol. 2, no. 4, pp. 212–213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Lloyd-Jones, R. Adams, M. Carnethon et al., “Heart disease and stroke statistics-2009 update. A report from the American heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 119, no. 3, pp. 480–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. G. Stead, L. Vaidyanathan, M. F. Bellolio et al., “Knowledge of signs, treatment and need for urgent management in patients presenting with an acute ischaemic stroke or transient ischaemic attack: a prospective study,” Emergency Medicine Journal, vol. 25, no. 11, pp. 735–739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. G. Stead, R. M. Gilmore, W. W. Decker, A. L. Weaver, and R. D. Brown Jr., “Initial emergency department blood pressure as predictor of survival after acute ischemic stroke,” Neurology, vol. 65, no. 8, pp. 1179–1183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. G. Stead, R. M. Gilmore, M. F. Bellolio et al., “Hyperglycemia as an independent predictor of worse outcome in non-diabetic patients presenting with acute ischemic stroke,” Neurocritical Care, vol. 10, no. 2, pp. 181–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. G. Stead, R. M. Gilmore, M. F. Bellolio et al., “Prolonged QTc as a predictor of mortality in acute ischemic stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 18, no. 6, pp. 469–474, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Tanne, N. Koren-Morag, E. Graff, and U. Goldbourt, “Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) registry: high triglycerides constitute an independent risk factor,” Circulation, vol. 104, no. 24, pp. 2892–2897, 2001. View at Google Scholar · View at Scopus
  8. P. Laloux, L. Galanti, and J. Jamart, “Lipids in ischemic stroke subtypes,” Acta Neurologica Belgica, vol. 104, no. 1, pp. 13–19, 2004. View at Google Scholar · View at Scopus
  9. T. Dziedzic, A. Slowik, E. A. Gryz, and A. Szczudlik, “Lower serum triglyceride level is associated with increased stroke severity,” Stroke, vol. 35, no. 6, pp. e151–e152, 2004. View at Google Scholar · View at Scopus
  10. W. Li, M. Liu, B. Wu, H. Liu, L. C. Wang, and S. Tan, “Serum lipid levels and 3-month prognosis in Chinese patients with acute stroke,” Advances in Therapy, vol. 25, no. 4, pp. 329–341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. J. Weir, N. Sattar, M. R. Walters, and K. R. Lees, “Low triglyceride, not low cholesterol concentration, independently predicts poor outcome following acute stroke,” Cerebrovascular Diseases, vol. 16, no. 1, pp. 76–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Simundic, N. Nikolac, E. Topic, V. Basic-Kes, and V. Demarin, “Are serum lipids measured on stroke admission prognostic?” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 8, pp. 1163–1167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Sulter, C. Steen, and J. De Keyser, “Use of the barthel index and modified rankin scale in acute stroke trials,” Stroke, vol. 30, no. 8, pp. 1538–1541, 1999. View at Google Scholar · View at Scopus
  14. G. R. Warnick, R. H. Knopp, V. Fitzpatrick, and L. Branson, “Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints,” Clinical Chemistry, vol. 36, no. 1, pp. 15–19, 1990. View at Google Scholar · View at Scopus
  15. W. S. Ryu, S. H. Lee, C. K. Kim, B. J. Kim, and B. W. Yoon, “Effects of low serum triglyceride on stroke mortality: a prospective follow-up study,” Atherosclerosis, vol. 212, no. 1, pp. 299–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. H. Choi, M. S. Park, J. T. Kim et al., “Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke,” Journal of the Neurological Sciences, vol. 319, no. 1-2, pp. 111–116, 2012. View at Publisher · View at Google Scholar
  17. S. Pikija, V. Trkulja, L. Juvan, M. Ivanec, and D. Dukši, “Higher on-admission serum triglycerides predict less severe disability and lower all-cause mortality after acute ischemic stroke,” Journal of Stroke and Cerebrovascular Diseases, 2012. View at Google Scholar
  18. S. Pikija, D. Milevčić, V. Trkulja, S. Kidemet-Piskač, I. Pavliček, and N. Sokol, “Higher serum triglyceride level in patients with acute ischemic stroke is associated with lower infarct volume on CT brain scans,” European Neurology, vol. 55, no. 2, pp. 89–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Bittner, Impact of Gender and Life Cycle on Triglyceride Levels, Medscape Family Medicine (CME), Omaha, Neb, USA, 2008.
  20. “Clinic M. Menopause,” http://www.mayoclinic.com/health/menopause/DS00119/DSECTION=symptoms.
  21. M. C. Carr, “The emergence of the metabolic syndrome with menopause,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2404–2411, 2003. View at Google Scholar · View at Scopus
  22. E. T. Poehlman, M. J. Toth, P. A. Ades, and C. J. Rosen, “Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study,” European Journal of Clinical Investigation, vol. 27, no. 4, pp. 322–326, 1997. View at Google Scholar · View at Scopus
  23. M. D. Carroll, D. A. Lacher, P. D. Sorlie et al., “Trends in serum lipids and lipoproteins of adults, 1960–2002,” Journal of the American Medical Association, vol. 294, no. 14, pp. 1773–1781, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. R. B. Verdery and R. L. Walford, “Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in biosphere 2,” Archives of Internal Medicine, vol. 158, no. 8, pp. 900–906, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Dennis, “Poor nutritional status on admission predicts poor outcomes after stroke observational data from the food trial,” Stroke, vol. 34, no. 6, pp. 1450–1455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Gariballa, S. G. Parker, N. Taub, and C. M. Castleden, “Influence of nutritional status on clinical outcome after acute stroke,” American Journal of Clinical Nutrition, vol. 68, no. 2, pp. 275–281, 1998. View at Google Scholar · View at Scopus